[
    [
        {
            "time": "2020-03-12",
            "original_text": "午间公告｜长春高新控股子公司一疫苗获得临床试验通知书",
            "features": {
                "keywords": [
                    "长春高新",
                    "子公司",
                    "疫苗",
                    "临床试验",
                    "通知书"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "午间公告｜长春高新控股子公司一疫苗获得临床试验通知书",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-03-12",
            "original_text": "长春高新：子公司百白破疫苗获准临床试验",
            "features": {
                "keywords": [
                    "长春高新",
                    "子公司",
                    "百白破疫苗",
                    "临床试验"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "长春高新：子公司百白破疫苗获准临床试验",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-03-12",
            "original_text": "长春高新：吸附无细胞百白破（三组分）联合疫苗获准临床试验",
            "features": {
                "keywords": [
                    "长春高新",
                    "吸附无细胞百白破",
                    "三组分",
                    "联合疫苗",
                    "临床试验"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "长春高新：吸附无细胞百白破（三组分）联合疫苗获准临床试验",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-03-12",
            "original_text": "[公司]长春高新技术控股子公司吸附无细胞百白破（三组分）联合疫苗获得临床试验通知书",
            "features": {
                "keywords": [
                    "长春高新",
                    "子公司",
                    "吸附无细胞百白破",
                    "三组分",
                    "联合疫苗",
                    "临床试验",
                    "通知书"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[公司]长春高新技术控股子公司吸附无细胞百白破（三组分）联合疫苗获得临床试验通知书",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        }
    ]
]